SB2549

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine products.

Complete·4/13/26

SB2549 amends Tennessee law to allow certain healthcare providers to administer buprenorphine products.

SB2549 amends Tennessee Code Annotated, Title 53 and Title 63, to allow healthcare providers employed by, contracting with, or subcontracting through the Department of Correction or a county or municipal jail to administer buprenorphine products. This change aims to expand access to these products for incarcerated individuals. The act takes effect immediately upon becoming law.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

D
1
1
R
Democratic CaucusRepublican Caucus

Roll Call Votes

30 Yea

RRRRRDRRRDRRDRRRRRRRRRRRRDRRRR

1 Nay

R

Calendar

Mar 4

1:00 PM

Senate Health And Welfare Hearing

Feb 25

1:00 PM

Senate Health And Welfare Hearing

History

Apr 13

Pub. Ch. 677

Apr 13

Effective date(s) 04/07/2026

Apr 7

Senate

Signed by Governor.